Showing 1 - 10 of 621
of the developing world introduces patent protection for new drug products. This may lead to more research on drugs to …
Persistent link: https://www.econbiz.de/10012471281
Pharmaceutical firms' use of secondary patents to extend periods of exclusivity generates concerns among policymakers worldwide. In response, some developing countries have introduced measures to curb the grant of these patents. While these measures have received considerable attention, there is...
Persistent link: https://www.econbiz.de/10012455567
therapeutic class of drugs. These effects emerge when use of a drug by others affects its value, and/or conveys information abut … data for H2-antagonist antiulcer drugs to estimate a dynamic demand model and quantify these effects. The model has three … brand valuation; equations relating equilibrium market shares to quality-adjusted prices and marketing levels; and diffusion …
Persistent link: https://www.econbiz.de/10012470978
Recent work linking the adoption of key organizational practices to productivity raises an important question: if adoption increases productivity so dramatically, why does adoption across an industry take so long? This paper explores this question in the context of one particularly interesting...
Persistent link: https://www.econbiz.de/10012471425
class of drugs. These effects emerge when use of a drug by others conveys information about its efficacy and safety to … market diffusion. Using data for H2-antagonist antiulcer drugs, we examine two aspects of these effects. First, we use …
Persistent link: https://www.econbiz.de/10012471776
to the conclusion of litigation. For the remainder, drugs that received FDA approval prior to a favorable district court … is analogous to a "buy out" of the patent with favorable welfare implications in both the short run (consumer prices) and …
Persistent link: https://www.econbiz.de/10012616579
Puerto Rico operated as a tax haven under U.S. Internal Revenue Code (IRC) Section 936. Firms in the pharmaceutical industry accounted for approximately 50% of tax credits awarded and 20% of employment under the program. The U.S. Congress eliminated the tax exemption program in 2006, creating a...
Persistent link: https://www.econbiz.de/10012599397
prices are much higher in the US. This fact has led policymakers to consider legislation for price controls. This paper … assesses the effects of a US international reference pricing policy that would cap prices in US markets by those offered in … like Canada where prices are set through a negotiation process between pharmaceutical companies and the government. We then …
Persistent link: https://www.econbiz.de/10013210081
Despite their importance to the supply of prescription drugs, there has been limited research on pharmacy benefit …
Persistent link: https://www.econbiz.de/10013191054
, which in turn reduces prices. However, regulatory approvals delay most entrants by 2-4 years. We then estimate a structural …
Persistent link: https://www.econbiz.de/10013172185